Top

18-12-2024 | Prediabetes | Original Article

Association between estimated glucose disposal rate and kidney function decline in different glucose tolerance statuses from the 4 C study

Authors: Peiqiong Luo, Danpei Li, Yaming Guo, Xiaoyu Meng, Ranran Kan, Xuefeng Yu

Abstract

Aims

To investigate the association between estimated glucose disposal rate (eGDR) and kidney function decline among populations with different glucose tolerance statuses including normal glucose tolerance (NGT), prediabetes, and diabetes.

Methods

The present study analyzed 5,069 participants from a cohort study. The association between eGDR and kidney function decline was assessed using binary logistic regression. Restricted cubic splines (RCS) analyses were also performed to investigate the dose-dependent associations.

Results

During up to 5 years of follow-up, 116 (2.30%) individuals experienced kidney function decline. Binary logistic regression showed that an increased level of eGDR was associated with decreased risk of kidney function decline after full adjustment, in all participants (Q4 vs. Q1 HR 0.13, 95% CI 0.05–0.30, p = 0.001), prediabetes (Q4 vs. Q1HR 0.11, 95% CI 0.01–0.44, p = 0.007), and diabetes (Q4 vs. Q1 HR 0.06, 95% CI 0.00-0.37, p = 0.012), but not in those with NGT. RCS analyses suggested dose-dependent relationships of eGDR with the risk of kidney function decline in all participants (L-shaped curve) and those with prediabetes (inverted U-shaped curve) and diabetes (L-shaped curve).

Conclusions

The association between elevated baseline eGDR and reduced risk of kidney function decline was significant in participants with prediabetes and diabetes, but not in those with NGT. These dose-dependent associations may have important implications for the assessment of high-risk patients by healthcare professionals and may lead to the development of more tailored and effective prevention strategies.

Available only for authorised users

Webster AC, Nagler EV, Morton RL et al (2017) Chronic kidney disease. Lancet 389(10075):1238–1252CrossRefPubMed

Levey AS, Stevens LA, Schmid CH et al (2009) A new equation to estimate glomerular filtration rate. Ann Intern Med 150(9):604–612CrossRefPubMedPubMedCentral

Linn W, Persson M, Rathsman B et al (2023) Estimated glucose disposal rate is associated with retinopathy and kidney disease in young people with type 1 diabetes: a nationwide observational study. Cardiovasc Diabetol 22(1):61CrossRefPubMedPubMedCentral

Lu Z, Xiong Y, Feng X et al (2023) Insulin resistance estimated by estimated glucose disposal rate predicts outcomes in acute ischemic stroke patients. Cardiovasc Diabetol 22(1):225CrossRefPubMedPubMedCentral

Peng J, Li A, Yin L et al (2023) Estimated glucose disposal rate predicts renal progression in type 2 diabetes Mellitus: a retrospective cohort study. J Endocr Soc 7(7):bvad069CrossRefPubMedPubMedCentral

Collaborators GBDD (2024) Global age-sex-specific mortality, life expectancy, and population estimates in 204 countries and territories and 811 subnational locations, 1950–2021, and the impact of the COVID-19 pandemic: a comprehensive demographic analysis for the global burden of disease study 2021. Lancet 403:1989CrossRef

He D, Gao B, Wang J et al (2024) Differences between cystatin C- and creatinine-based estimated glomerular filtration rate and association with mortality and cardiovascular events: results from three cohorts of adults with diabetes. Nephrol Dial Transplant

Kawada T (2024) Estimated glomerular filtration rate and risk of all-cause mortality. J Diabetes 16(3):e13513CrossRefPubMed

Kim YH, Lee W, Kim KY et al (2024) The estimated mediating roles of anemia-related variables in the association between kidney function and mortality: a National Health and Nutrition Examination Survey (NHANES) study. Sci Rep 14(1):6621CrossRefPubMedPubMedCentral

10.

Wang D, Hu X, Jin H et al (2024) Impaired kidney function and the risk of all-cause mortality and cardiovascular disease among Chinese hypertensive adults: using three different equations to estimate the glomerular filtration rate. Prev Med 180:107869CrossRefPubMed

11.

Zhang Z, Zhao L, Lu Y et al (2024) Insulin resistance assessed by estimated glucose disposal rate and risk of incident cardiovascular diseases among individuals without diabetes: findings from a nationwide, population based, prospective cohort study. Cardiovasc Diabetol 23(1):194CrossRefPubMedPubMedCentral

12.

Spoto B, Pisano A, Zoccali C (2016) Insulin resistance in chronic kidney disease: a systematic review. Am J Physiol Ren Physiol 311(6):F1087–F108CrossRef

13.

Epstein EJ, Osman JL, Cohen HW et al (2013) Use of the estimated glucose disposal rate as a measure of insulin resistance in an urban multiethnic population with type 1 diabetes. Diabetes Care 36(8):2280–2285CrossRefPubMedPubMedCentral

14.

Nystrom T, Holzmann MJ, Eliasson B et al (2017) Estimated glucose disposal rate and long-term survival in type 2 diabetes after coronary artery bypass grafting. Heart Vessels 32(3):269–278CrossRefPubMed

15.

Zou H, Xu Y, Chen X et al (2020) Predictive values of ANGPTL8 on risk of all-cause mortality in diabetic patients: results from the REACTION study. Cardiovasc Diabetol 19(1):121CrossRefPubMedPubMedCentral

16.

Gong L, Wang C, Ning G et al (2021) High concentrations of triglycerides are associated with diabetic kidney disease in new-onset type 2 diabetes in China: findings from the China Cardiometabolic Disease and Cancer Cohort (4 C) study. Diabetes Obes Metab 23(11):2551–2560CrossRefPubMedPubMedCentral

17.

Zhu Y, Zou H, Guo Y et al (2023) Associations between metabolic score for visceral fat and the risk of cardiovascular disease and all-cause mortality among populations with different glucose tolerance statuses. Diabetes Res Clin Pract 203:110842CrossRefPubMed

18.

Ma YC, Zuo L, Chen JH et al (2006) Modified glomerular filtration rate estimating equation for Chinese patients with chronic kidney disease. J Am Soc Nephrol 17(10):2937–2944CrossRefPubMed

19.

Penno G, Solini A, Orsi E et al (2021) Insulin resistance, diabetic kidney disease, and all-cause mortality in individuals with type 2 diabetes: a prospective cohort study. BMC Med 19(1):66CrossRefPubMedPubMedCentral

20.

De Cosmo S, Menzaghi C, Prudente S et al (2013) Role of insulin resistance in kidney dysfunction: insights into the mechanism and epidemiological evidence. Nephrol Dial Transpl 28(1):29–36CrossRef

21.

Jairoun AA, Ping CC, Ibrahim B (2024) Predictors of chronic kidney disease survival in type 2 diabetes: a 12-year retrospective cohort study utilizing estimated glomerular filtration rate. Sci Rep 14(1):9014CrossRefPubMedPubMedCentral

22.

Echouffo-Tcheugui JB, Narayan KM, Weisman D et al (2016) Association between prediabetes and risk of chronic kidney disease: a systematic review and meta-analysis. Diabet Med 33(12):1615–1624CrossRefPubMed

23.

Kazancioglu R (2013) Risk factors for chronic kidney disease: an update. Kidney Int Suppl (2011) 3(4):368–371CrossRefPubMed

24.

Schroijen MA, de Mutsert R, Dekker FW et al (2021) The association of glucose metabolism and kidney function in middle-aged adults. Clin Kidney J 14(11):2383–2390CrossRefPubMedPubMedCentral

25.

Wang X, Fan F, Jia J et al (2018) Association of different glucose traits with kidney function decline risk in a Chinese community-based population without chronic kidney disease. Ther Clin Risk Manag 14:1725–1734CrossRefPubMedPubMedCentral

26.

Khan RMM, Chua ZJY, Tan JC et al (2019) From pre-diabetes to diabetes: diagnosis, treatments and translational research. Med (Kaunas) 55(9):546

27.

Tabak AG, Herder C, Rathmann W et al (2012) Prediabetes: a high-risk state for diabetes development. Lancet 379(9833):2279–2290CrossRefPubMedPubMedCentral

28.

Breyer MK, Ofenheimer A, Altziebler J et al (2020) Marked differences in prediabetes- and diabetes-associated comorbidities between men and women-epidemiological results from a general population-based cohort aged 6–80 years-the LEAD (lung, hEart, sociAl, boDy) study. Eur J Clin Invest 50(3):e13207CrossRefPubMed

29.

Echouffo-Tcheugui JB, Selvin E (2021) Prediabetes and what it means: the Epidemiological evidence. Annu Rev Public Health 42:59–77CrossRefPubMedPubMedCentral

30.

Bansal N (2015) Prediabetes diagnosis and treatment: a review. World J Diabetes 6(2):296–303CrossRefPubMedPubMedCentral

31.

Liu J, Yi SS, Russo R et al (2023) Trends and disparities in diabetes and prediabetes among adults in the United States, 1999–2018. Public Health 214:163–170CrossRefPubMed

32.

Li H, Zuo Y, Qian F et al (2022) Triglyceride-glucose index variability and incident cardiovascular disease: a prospective cohort study. Cardiovasc Diabetol 21(1):105CrossRefPubMedPubMedCentral

33.

Levey AS, Inker LA, Coresh J (2014) GFR estimation: from physiology to public health. Am J Kidney Dis 63(5):820–834CrossRefPubMedPubMedCentral

34.

Hade EM, Lu B (2014) Bias associated with using the estimated propensity score as a regression covariate. Stat Med 33(1):74–87CrossRefPubMed

35.

Hariton E, Locascio JJ (2018) Randomised controlled trials - the gold standard for effectiveness research: study design: randomised controlled trials. BJOG 125(13):1716CrossRefPubMedPubMedCentral

36.

Davies NM, Holmes MV, Davey Smith G (2018) Reading mendelian randomisation studies: a guide, glossary, and checklist for clinicians. BMJ 362:k601CrossRefPubMedPubMedCentral

Title: Association between estimated glucose disposal rate and kidney function decline in different glucose tolerance statuses from the 4 C study
Authors: Peiqiong Luo
Danpei Li
Yaming Guo
Xiaoyu Meng
Ranran Kan
Xuefeng Yu
Publication date: 18-12-2024
Publisher: Springer Milan
Keywords: Prediabetes
Insulins
Insulins
Chronic Kidney Disease
Published in: Acta Diabetologica
Print ISSN: 0940-5429
Electronic ISSN: 1432-5233
DOI: https://doi.org/10.1007/s00592-024-02432-9

Elevate your expertise in aplastic anemia (Link opens in a new window)

Aplastic Anemia
Independent Medical Education

Transform the way you care for your patients with aplastic anemia with our 3-module series using real-world case studies and expert insights. Discover why early diagnosis matters, explore the benefits and risks of current treatments, and develop tailored approaches for complex cases.

Supported by:

Pfizer

Developed by: Springer Healthcare IME

Learn more

Keynote series | Spotlight on menopause

Menopause
Video Series

Menopause can have a significant impact on the body, with effects ranging beyond the endocrine and reproductive systems. Learn about the systemic effects of menopause, so you can help patients in your clinics through the transition.

Prof. Martha Hickey

Dr. Claudia Barth

Dr. Samar El Khoudary

Developed by: Springer Medicine

Watch now